Tag Archives: nicholas ashton

Novel research by Nicholas Ashton reveals Alzheimer´s disease in blood test long before clinical symptoms occur

Research conducted by Dr. Nicholas Ashton, Gothenburg University and MedTech West, has added further evidence in the possible utility of a blood test for predicting Alzheimer’s disease (AD). Using a mass spectrometry technique, the results show that a particular profile of proteins in blood was very accurate in predicting individuals with AD pathology in brain…
Read more

Nicholas Ashton publishes interesting results regarding Alzheimer´s blood test

Nicholas Ashton, researcher at Wallenberg Centre for Molecular and Translational Medicine at University of Gothenburg and MedTech West, is first author of an article titled “Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration“ published in Acta Neuropathologica Communications. The published results show for the first time that axonal…
Read more

First edition of “Biomarkers in neurodegenerative disorders” PhD course

The first edition of a new PhD course on Biomarkers in neurodegenerative disorders took place on 9-13 April at the University of Gothenburg’s Sahlgrenska Academy, Wallenberg Centre. The course featured lectures and interactive group assignments on a range of topics covering biomarkers in blood and cerebrospinal fluid, as well as PET and MRI-imaging of neurodegeneration…
Read more

Nick Ashton at London Science Museum

On Saturday 24 March, Nicholas Ashton, postdoc in Michael Schöll´s Research Group, gave a speech at the prestigious London Science Museum as part of the public event “Delve into Dementia”. Nick´s talk focused on the challenge of diagnosing preclinical Alzheimer’s disease and why it is critical, even when there is currently no cure. He presented…
Read more